Drug Trial Radar · NCT03760562
The Risk of Hypertension Associated With Oral Glucocorticoids in Chronic Inflammatory Diseases
Last checked: Nov 19, 2026Latest source record: Nov 30, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
111,804
Actual
Start
Jan 1, 1998
Primary completion
Jan 30, 2015
Study completion Sep 30, 2015
Sponsor
- Lead sponsor
- University of LeedsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 30, 2018
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
Glucocorticoids are widely used for the treatment of chronic inflammatory diseases. In 2008, it was estimated that 0.8% of the United Kingdom adult population had used long-term (≥ 3 months) glucocorticoids, rising to 3% in women aged over 80 years. The aim of the project is to investigate the dose-response estimates of risk of high blood pressure associated with oral glucocorticoids.
Conditions
- Hypertension
Interventions
GlucocorticoidsDrug
Oral Glucocorticoids.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Glucocorticoid-related hypertensionTime frame: 18 years
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.